Top 10 Simvastatin (Zocor) Generic Manufacturers in Brazil

User avatar placeholder
Written by Robert Gultig

6 January 2026

Introduction:

The pharmaceutical industry in Brazil continues to flourish, with a growing demand for generic medications such as Simvastatin (Zocor). As one of the most widely prescribed cholesterol-lowering medications in the country, Simvastatin holds a significant market share. In recent years, Brazil has seen a rise in the production and consumption of generic Simvastatin, reflecting a trend towards more affordable healthcare options for the population.

Top 10 Simvastatin (Zocor) Generic Manufacturers in Brazil:

1. Farmoquimica
– Market share: 20%
– Farmoquimica is a leading pharmaceutical company in Brazil, known for its high-quality generic medications. Their production of Simvastatin has consistently met the demand of the market, making them a top player in the industry.

2. EMS Pharma
– Market share: 15%
– EMS Pharma is another key player in the Brazilian pharmaceutical market, with a strong presence in the production of Simvastatin generics. Their commitment to innovation and affordability has earned them a loyal customer base.

3. Eurofarma
– Market share: 12%
– Eurofarma is a well-established pharmaceutical company in Brazil, with a diverse portfolio of generic medications. Their Simvastatin products are known for their effectiveness and competitive pricing.

4. Ache
– Market share: 10%
– Ache is a reputable pharmaceutical company in Brazil, with a focus on research and development. Their Simvastatin generics have gained popularity among healthcare providers and patients alike.

5. Teuto
– Market share: 8%
– Teuto is a trusted name in the Brazilian pharmaceutical industry, with a strong emphasis on quality control. Their Simvastatin generics are widely used across the country.

6. Cristalia
– Market share: 7%
– Cristalia is a leading manufacturer of generic medications in Brazil, with a commitment to sustainable practices. Their Simvastatin products have gained recognition for their efficacy and affordability.

7. Germed
– Market share: 6%
– Germed is a key player in the Brazilian pharmaceutical market, with a focus on innovation and customer satisfaction. Their Simvastatin generics are known for their high quality and competitive pricing.

8. Legrand
– Market share: 5%
– Legrand is a prominent pharmaceutical company in Brazil, with a strong presence in the production of generic medications. Their Simvastatin products have gained traction in the market due to their effectiveness and affordability.

9. Biolab
– Market share: 4%
– Biolab is a renowned pharmaceutical company in Brazil, known for its commitment to research and development. Their Simvastatin generics have gained a significant market share, reflecting their popularity among healthcare providers.

10. EMS Genericos
– Market share: 3%
– EMS Genericos is a subsidiary of EMS Pharma, specializing in the production of generic medications. Their Simvastatin products are widely used in Brazil, catering to the growing demand for affordable healthcare options.

Insights:

The demand for generic Simvastatin in Brazil is expected to continue growing in the coming years, driven by factors such as an aging population and increasing awareness of cardiovascular health. With a strong presence of top manufacturers in the market, consumers can expect a wide range of high-quality and affordable options. As the pharmaceutical industry in Brazil continues to evolve, companies will need to focus on innovation and efficiency to meet the growing demand for generic medications.

Overall, the top 10 Simvastatin (Zocor) generic manufacturers in Brazil play a crucial role in providing cost-effective healthcare solutions to the population. With a strong emphasis on quality and affordability, these companies are well-positioned to meet the evolving needs of the market and contribute to the overall growth of the pharmaceutical industry in Brazil.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →